메뉴 건너뛰기
Multiple Sclerosis Journal
Volumn 19, Issue 2, 2013, Pages 162-166
The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: A meta-analysis
Author keywords

case control studies; Epstein Barr virus; meta analysis; Multiple sclerosis
Indexed keywords

ANTIBODY;
EID: 84873663540     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458512449682     Document Type: Article
Times cited : (136)
References (34)
  • 2
    • 0017869323 scopus 로고
    • Viral antibodies in multiple sclerosis
    • Norrby E. Viral antibodies in multiple sclerosis. Prog Med Virol. 1978 ; 24: 1-39
    • (1978) Prog Med Virol , vol.24 , pp. 1-39
    • Norrby, E.1
  • 3
    • 11244266124 scopus 로고    scopus 로고
    • Latent and lytic Epstein-Barr virus replication strategies
    • Tsurumi T, Fujita M, Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol. 2005 ; 15: 3-15
    • (2005) Rev Med Virol , vol.15 , pp. 3-15
    • Tsurumi, T.1    Fujita, M.2    Kudoh, A.3
  • 4
  • 5
    • 77958600548 scopus 로고    scopus 로고
    • An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis
    • Handel AE, Williamson AJ, Disanto G, et al. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PloS One. 2010 ; 5 (9). e12496
    • (2010) PloS One , vol.5 , Issue.9 , pp. 12496
    • Handel, A.E.1    Williamson, A.J.2    Disanto, G.3
  • 6
    • 77953394241 scopus 로고    scopus 로고
    • Multiple sclerosis: Risk factors, prodromes, and potential causal pathways
    • Ramagopalan SV, Dobson R, Meier UC, et al. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010 ; 9: 727-739
    • (2010) Lancet Neurol , vol.9 , pp. 727-739
    • Ramagopalan, S.V.1    Dobson, R.2    Meier, U.C.3
  • 7
    • 34247590137 scopus 로고    scopus 로고
    • Environmental risk factors for multiple sclerosis. Part I: The role of infection
    • Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol. 2007 ; 61: 288-299
    • (2007) Ann Neurol , vol.61 , pp. 288-299
    • Ascherio, A.1    Munger, K.L.2
  • 8
    • 0035956494 scopus 로고    scopus 로고
    • Epstein-Barr virus antibodies and risk of multiple sclerosis : A prospective study
    • Ascherio A, Munger KL, Lennette ET, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA. 2001 ; 286: 3083-3088
    • (2001) JAMA , vol.286 , pp. 3083-3088
    • Ascherio, A.1    Munger, K.L.2    Lennette, E.T.3
  • 9
    • 0020639761 scopus 로고
    • Epstein-Barr virus-infection and antibody-synthesis in patients with multiple-sclerosis
    • Bray PF, Bloomer LC, Salmon VC, et al. Epstein-Barr virus-infection and antibody-synthesis in patients with multiple-sclerosis. Arch Neurol. 1983 ; 40: 406-408
    • (1983) Arch Neurol , vol.40 , pp. 406-408
    • Bray, P.F.1    Bloomer, L.C.2    Salmon, V.C.3
  • 10
    • 1642565888 scopus 로고    scopus 로고
    • A role of late Epstein-Barr virus infection in multiple sclerosis
    • Haahr S, Plesner AM, Vestergaard BF, et al. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand. 2004 ; 109: 270-275
    • (2004) Acta Neurol Scand , vol.109 , pp. 270-275
    • Haahr, S.1    Plesner, A.M.2    Vestergaard, B.F.3
  • 11
    • 0021949843 scopus 로고
    • Epstein-Barr nuclear antigen and viral capsid antigen-antibody titers in multiple-sclerosis
    • Larsen PD, Bloomer LC, Bray PF. Epstein-Barr nuclear antigen and viral capsid antigen-antibody titers in multiple-sclerosis. Neurology. 1985 ; 35: 435-438
    • (1985) Neurology , vol.35 , pp. 435-438
    • Larsen, P.D.1    Bloomer, L.C.2    Bray, P.F.3
  • 12
    • 0030626495 scopus 로고    scopus 로고
    • The implications of Epstein-Barr virus in multiple sclerosis: A review
    • Munch M, Hvas J, Christensen T, et al. The implications of Epstein-Barr virus in multiple sclerosis: a review. Acta Neurol Scand. 1997 ; 95: 59-64
    • (1997) Acta Neurol Scand , vol.95 , pp. 59-64
    • Munch, M.1    Hvas, J.2    Christensen, T.3
  • 13
    • 0031967440 scopus 로고    scopus 로고
    • Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: A population based case-control study from western Norway
    • Myhr KM, Riise T, Barrett-Connor E, et al. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. J Neurol Neurosurg Psychiatry. 1998 ; 64: 539-542
    • (1998) J Neurol Neurosurg Psychiatry , vol.64 , pp. 539-542
    • Myhr, K.M.1    Riise, T.2    Barrett-Connor, E.3
  • 14
    • 12544258106 scopus 로고    scopus 로고
    • Exposure to infant siblings during early life and risk of multiple sclerosis
    • Ponsonby AL, Van der Mei I, Dwyer T, et al. Exposure to infant siblings during early life and risk of multiple sclerosis. JAMA. 2005 ; 293: 463-469
    • (2005) JAMA , vol.293 , pp. 463-469
    • Ponsonby, A.L.1    Van Der Mei, I.2    Dwyer, T.3
  • 15
    • 0023515435 scopus 로고
    • Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis
    • Shirodaria PV, Haire M, Fleming E, et al. Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol. 1987 ; 44: 1237-1241
    • (1987) Arch Neurol , vol.44 , pp. 1237-1241
    • Shirodaria, P.V.1    Haire, M.2    Fleming, E.3
  • 16
    • 0018870211 scopus 로고
    • Epstein-Barr virus antibodies in multiple sclerosis
    • Sumaya CV, Myers LW, Ellison GW. Epstein-Barr virus antibodies in multiple sclerosis. Arch Neurol. 1980 ; 37: 94-96
    • (1980) Arch Neurol , vol.37 , pp. 94-96
    • Sumaya, C.V.1    Myers, L.W.2    Ellison, G.W.3
  • 17
    • 0021888308 scopus 로고
    • Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis
    • Sumaya CV, Myers LW, Ellison GW, et al. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol. 1985 ; 17: 371-377
    • (1985) Ann Neurol , vol.17 , pp. 371-377
    • Sumaya, C.V.1    Myers, L.W.2    Ellison, G.W.3
  • 18
    • 2942752168 scopus 로고    scopus 로고
    • An altered immune response to Epstein-Barr virus in multiple sclerosis: A prospective study
    • Sundstrom P, Juto P, Wadell G, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology. 2004 ; 62: 2277-2282
    • (2004) Neurology , vol.62 , pp. 2277-2282
    • Sundstrom, P.1    Juto, P.2    Wadell, G.3
  • 19
    • 0034507210 scopus 로고    scopus 로고
    • Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis
    • Wagner HJ, Hennig H, Jabs WJ, et al. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis. Viral Immunol. 2000 ; 13: 497-502
    • (2000) Viral Immunol , vol.13 , pp. 497-502
    • Wagner, H.J.1    Hennig, H.2    Jabs, W.J.3
  • 20
    • 0023358678 scopus 로고
    • The Italian Cooperative Multiple Sclerosis case-control study: Preliminary results on viral antibodies
    • Ferrante P, Castellani P, Barbi MF, et al. The Italian Cooperative Multiple Sclerosis case-control study: preliminary results on viral antibodies. Ital J Neurol Sci. 1987 ;: 45-50
    • (1987) Ital J Neurol Sci , pp. 45-50
    • Ferrante, P.1    Castellani, P.2    Barbi, M.F.3
  • 21
    • 46849084346 scopus 로고    scopus 로고
    • Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
    • Jilek S, Schluep M, Meylan P, et al. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain. 2008 ; 131: 1712-1721
    • (2008) Brain , vol.131 , pp. 1712-1721
    • Jilek, S.1    Schluep, M.2    Meylan, P.3
  • 22
    • 77952921203 scopus 로고    scopus 로고
    • Primary infection with the Epstein-Barr virus and risk of multiple sclerosis
    • Levin LI, Munger KL, O'Reilly EJ, et al. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol. 2010 ; 67: 824-830
    • (2010) Ann Neurol , vol.67 , pp. 824-830
    • Levin, L.I.1    Munger, K.L.2    O'Reilly, E.J.3
  • 23
    • 77956641922 scopus 로고    scopus 로고
    • Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis
    • Lindsey JW, Hatfield LM, Vu T. Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis. Eur J Neurol. 2010 ; 17: 1263-1269
    • (2010) Eur J Neurol , vol.17 , pp. 1263-1269
    • Lindsey, J.W.1    Hatfield, L.M.2    Vu, T.3
  • 24
    • 79955042834 scopus 로고    scopus 로고
    • Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients
    • Villegas E, Santiago O, Carrillo JA, et al. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients. Diagn Microbiol Infect Dis. 2011 ; 70: 85-90
    • (2011) Diagn Microbiol Infect Dis , vol.70 , pp. 85-90
    • Villegas, E.1    Santiago, O.2    Carrillo, J.A.3
  • 25
    • 33646816323 scopus 로고    scopus 로고
    • Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients
    • Zivadinov R, Nasuelli D, Tommasi MA, et al. Positivity of cytomegalovirus antibodies predicts a better clinical and radiological outcome in multiple sclerosis patients. Neurol Res. 2006 ; 28: 262-269
    • (2006) Neurol Res , vol.28 , pp. 262-269
    • Zivadinov, R.1    Nasuelli, D.2    Ma, T.3
  • 26
    • 36749079245 scopus 로고    scopus 로고
    • Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis
    • Riverol M, Sepulcre J, Fernandez-Diez B, et al. Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of multiple sclerosis. J Neuroimmunol. 2007 ; 192: 184-185
    • (2007) J Neuroimmunol , vol.192 , pp. 184-185
    • Riverol, M.1    Sepulcre, J.2    Fernandez-Diez, B.3
  • 27
    • 33750605408 scopus 로고    scopus 로고
    • Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls
    • Gronen F, Ruprecht K, Weissbrich B, et al. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls. J Neuroimmunol. 2006 ; 180: 185-192
    • (2006) J Neuroimmunol , vol.180 , pp. 185-192
    • Gronen, F.1    Ruprecht, K.2    Weissbrich, B.3
  • 28
    • 78650455250 scopus 로고    scopus 로고
    • Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity
    • Ingram G, Bugert JJ, Loveless S, et al. Anti-EBNA-1 IgG is not a reliable marker of multiple sclerosis clinical disease activity. Eur J Neurol. 2010 ; 17: 1386-1389
    • (2010) Eur J Neurol , vol.17 , pp. 1386-1389
    • Ingram, G.1    Bugert, J.J.2    Loveless, S.3
  • 29
    • 79959372353 scopus 로고    scopus 로고
    • Evaluation of viral antibodies in Iranian multiple sclerosis patients
    • Khaki M, Ghazavi A, Ghasami K, et al. Evaluation of viral antibodies in Iranian multiple sclerosis patients. Neurosciences (Riyadh). 2011 ; 16: 224-228
    • (2011) Neurosciences (Riyadh) , vol.16 , pp. 224-228
    • Khaki, M.1    Ghazavi, A.2    Ghasami, K.3
  • 30
    • 33845706602 scopus 로고    scopus 로고
    • High seroprevalence of Epstein-Barr virus in children with multiple sclerosis
    • Pohl D, Krone B, Rostasy K, et al. High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology. 2006 ; 67: 2063-2065
    • (2006) Neurology , vol.67 , pp. 2063-2065
    • Pohl, D.1    Krone, B.2    Rostasy, K.3
  • 31
    • 1942478620 scopus 로고    scopus 로고
    • Epstein-Barr virus in pediatric multiple sclerosis
    • Alotaibi S, Kennedy J, Tellier R, et al. Epstein-Barr virus in pediatric multiple sclerosis. JAMA. 2004 ; 291: 1875-1879
    • (2004) JAMA , vol.291 , pp. 1875-1879
    • Alotaibi, S.1    Kennedy, J.2    Tellier, R.3
  • 32
    • 34547754534 scopus 로고    scopus 로고
    • Clinical features and viral serologies in children with multiple sclerosis: A multinational observational study
    • Banwell B, Krupp L, Kennedy J, et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol. 2007 ; 6: 773-781
    • (2007) Lancet Neurol , vol.6 , pp. 773-781
    • Banwell, B.1    Krupp, L.2    Kennedy, J.3
  • 33
    • 79952553854 scopus 로고    scopus 로고
    • Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections
    • De Ory F, Guisasola ME, Sanz JC, et al. Evaluation of four commercial systems for the diagnosis of Epstein-Barr virus primary infections. Clin Vaccine Immunol. 2011 ; 18: 444-448
    • (2011) Clin Vaccine Immunol , vol.18 , pp. 444-448
    • De Ory, F.1    Guisasola, M.E.2    Sanz, J.C.3
  • 34
    • 76049083072 scopus 로고    scopus 로고
    • Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma
    • Wang WY, Twu CW, Chen HH, et al. Plasma EBV DNA clearance rate as a novel prognostic marker for metastatic/recurrent nasopharyngeal carcinoma. Clin Cancer Res. 2010 ; 16: 1016-1024
    • (2010) Clin Cancer Res , vol.16 , pp. 1016-1024
    • Wang, W.Y.1    Twu, C.W.2    Chen, H.H.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.